Connected health firm Withings has unveiled its new in-home biomarker analysis platform U-Scan. It is hoped the device will utilise the “wealth of health information in daily urine.”
U-Scan is a urine health monitor that fits into the toilet bowl and is engineered to distinguish between extremal liquid and urine. A pump is activated when the thermal sensor detects urine, which “starts the sample’s f luidic journey within a microf luidic circuit”, according to Withings. The monitor then connects to the Withings Health Mate app: an in-home urine analysis platform that delivers information and insights based on daily readings.
The health monitor ‒ apebbleshaped reader ‒ also involves changeable analysis cartridges to evaluate specific biomarkers. The platform will debut with two consumer cartridges and move into medical in the future. The cartridges are U-Scan Nutri Balance, a metabolic guide to hydration and nutrition, and U-Scan Cycle Sync, which tracks and synchronises women’s monthly cycles.
Although the U-Scan is in development in the US, it will not be available until it is cleared by the FDA.
Withings CEO Mathieu Letombe said: “The ability of U-Scan to perform daily urine analysis from the home will allow Withings to take its mission to help consumers fully utilise urine data to an entirely new level. It’s one of the most exciting and complex products we have ever announced. We begin this journey with U-Scan Cycle Sync and Nutri Balance, and look forward to announcing more cartridges on an ongoing basis as well as medical applications of the technology.”
Pharmaceutical Industry news, analysis and insights